Clinical Trials Logo

HIV CDC Category A1 clinical trials

View clinical trials related to HIV CDC Category A1.

Filter by:
  • None
  • Page 1

NCT ID: NCT02765659 Completed - HIV CDC Category A1 Clinical Trials

A Community-based Implementation Model for HIV Prevention and Testing in Malawi

Start date: June 2016
Phase: N/A
Study type: Interventional

This implementation study is testing whether community members can use a 3-step model (prepare, roll-out and sustain) to implement an efficacious peer group HIV prevention intervention with fidelity and effectiveness in a single district in Southern Malawi. A collaborative partnership including university researchers and district government, health system and traditional leaders will support community volunteers in implementation. Both the implementation process and the effectiveness of the intervention when implemented by communities will be evaluated.

NCT ID: NCT02206932 Withdrawn - Clinical trials for Hepatitis C, Chronic

A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C

Start date: August 2014
Phase: Phase 4
Study type: Interventional

This is a study of the safety and effectiveness of the hepatitis C medications sofosbuvir and simeprevir in patients who have both the HIV and hepatitis C (HCV) viruses.

NCT ID: NCT01722838 Completed - HIV CDC Category A1 Clinical Trials

Black Men Evolving Behavioral HIV Prevention Intervention for Black MSM

B-ME
Start date: September 2012
Phase: N/A
Study type: Interventional

B-ME is a research intervention study designed to address the needs of African American men who have sex with men (AAMSM) who are at high risk for HIV. The intent of the intervention is to decrease HIV risk behaviors among African American MSM using an intervention developed by and for African American MSM. The hypothesis guiding this study is: that participants who complete B-ME intervention will report greater reductions in sexual risk behaviors than the standard of care comparison group.